Chief Medical OfficerHumacyte Global Inc.
SS17 - Acellular Tissue Engineered Vessel Outperforms Arteriovenous Fistula in High-Risk Patients on Hemodialysis: Results from the CLN-PRO-V007 Randomized Controlled Trial
Friday, June 6, 202510:50 AM – 11:00 AM CT